273 related articles for article (PubMed ID: 31314077)
1. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
3. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
[TBL] [Abstract][Full Text] [Related]
4. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
6. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
7. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
9. Predictors of slow progression to diabetes in children with multiple islet autoantibodies.
Steck AK; Dong F; Waugh K; Frohnert BI; Yu L; Norris JM; Rewers MJ
J Autoimmun; 2016 Aug; 72():113-7. PubMed ID: 27255734
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
[TBL] [Abstract][Full Text] [Related]
11. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.
Siljander H; Härkönen T; Hermann R; Simell S; Hekkala A; Salonsaari RT; Simell T; Simell O; Ilonen J; Veijola R; Knip M
Diabetes Metab Res Rev; 2009 Oct; 25(7):615-22. PubMed ID: 19637309
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
[TBL] [Abstract][Full Text] [Related]
16. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
[TBL] [Abstract][Full Text] [Related]
17. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Mäkinen A; Härkönen T; Ilonen J; Knip M;
Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
[TBL] [Abstract][Full Text] [Related]
20. Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.
Maziarz M; Hagopian W; Palmer JP; Sanjeevi CB; Kockum I; Breslow N; Lernmark Å; ; ;
Genes Immun; 2015 Dec; 16(8):541-51. PubMed ID: 26513234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
